QNTM vs. META

Last updated Jun 24, 2026

QNTM (Quantum BioPharma Ltd) and META (Meta Platforms, Inc.) are both stocks. QNTM operates in Biotechnology (Healthcare), while META operates in Internet Content & Information (Communication Services). Over the past 5 years, QNTM returned -49.48%/yr vs 10.57%/yr for META. At a 0.13 correlation, their price movements are largely independent.

Performance

QNTM vs. META - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Quantum BioPharma Ltd (QNTM) and Meta Platforms, Inc. (META). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, QNTM achieves a -47.26% return, which is significantly lower than META's -14.67% return.

QNTM

• 1D: 5.19%
• 1M: -58.33%
• YTD: -47.26%
• 6M: -59.30%
• 1Y: -83.27%
• 3Y*: -64.46%
• 5Y*: -49.48%
• 10Y*: —

META

• 1D: -0.29%
• 1M: -7.79%
• YTD: -14.67%
• 6M: -15.30%
• 1Y: -19.25%
• 3Y*: 25.24%
• 5Y*: 10.57%
• 10Y*: 17.60%

*Multi-year figures are annualized to reflect compound growth (CAGR)

QNTM vs. META - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018
QNTM Quantum BioPharma Ltd	-47.26%	98.37%	-93.84%	16.67%	-22.71%	-34.62%	-71.27%	-87.38%	145.98%
META Meta Platforms, Inc.	-14.67%	13.09%	66.05%	194.13%	-64.22%	23.13%	33.09%	56.57%	-30.34%

Correlation

The correlation between QNTM and META is 0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.05
Correlation (3Y) Calculated over the trailing 3-year period	0.10
Correlation (5Y) Calculated over the trailing 5-year period	0.11
Correlation (All Time) Calculated using the full available price history since Jun 8, 2018	0.13

Fundamentals

Market Cap QNTM : $17.28M META : $1.44T
EPS QNTM : -$8.16 META : $27.47
PB Ratio QNTM : 28.94 META : 5.92
Total Revenue (TTM) QNTM : $0.00 META : $214.96B
Gross Profit (TTM) QNTM : -$400.75K META : $176.14B
EBITDA (TTM) QNTM : -$18.93M META : $106.31B

Return for Risk

QNTM vs. META — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

QNTM

QNTM Risk / Return Rank: 14
QNTM Sharpe Ratio Rank: 18
QNTM Sortino Ratio Rank: 15
QNTM Omega Ratio Rank: 17
QNTM Calmar Ratio Rank: 7
QNTM Martin Ratio Rank: 14

META

META Risk / Return Rank: 19
META Sharpe Ratio Rank: 19
META Sortino Ratio Rank: 19
META Omega Ratio Rank: 19
META Calmar Ratio Rank: 21
META Martin Ratio Rank: 16

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

QNTM vs. META - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Quantum BioPharma Ltd (QNTM) and Meta Platforms, Inc. (META). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	QNTM	META	Difference
Sharpe ratio: Return per unit of total volatility	-0.55	-0.54	-0.02
Sortino ratio: Return per unit of downside risk	-0.83	-0.58	-0.24
Omega ratio: Gain probability vs. loss probability	0.91	0.93	-0.01
Calmar ratio: Return relative to maximum drawdown	-0.90	-0.58	-0.32
Martin ratio: Return relative to average drawdown	-1.22	-1.16	-0.06

QNTM vs. META - Sharpe Ratio Comparison

The current QNTM Sharpe Ratio is -0.55, which is comparable to the META Sharpe Ratio of -0.54. The chart below compares the historical Sharpe Ratios of QNTM and META, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

QNTM vs. META - Drawdown Comparison

The maximum QNTM drawdown since its inception was -99.98%, which is greater than META's maximum drawdown of -76.74%. Use the drawdown chart below to compare losses from any high point for QNTM and META.

Drawdown Indicators

	QNTM	META	Difference
Max Drawdown Largest peak-to-trough decline	-99.98%	-76.74%	-23.24%
Max Drawdown (1Y) Largest decline over 1 year	-92.81%	-33.30%	-59.51%
Max Drawdown (3Y) Largest decline over 3 years	-97.98%	-34.15%	-63.83%
Max Drawdown (5Y) Largest decline over 5 years	-98.42%	-76.74%	-21.68%
Max Drawdown (10Y) Largest decline over 10 years	—	-76.74%	—
Current Drawdown Current decline from peak	-99.96%	-28.60%	-71.36%
Average Drawdown Average peak-to-trough decline	-92.23%	-15.84%	-76.39%
Ulcer Index Depth and duration of drawdowns from previous peaks	68.15%	16.58%	+51.57%

Volatility

QNTM vs. META - Volatility Comparison

Quantum BioPharma Ltd (QNTM) has a higher volatility of 45.52% compared to Meta Platforms, Inc. (META) at 12.90%. This indicates that QNTM's price experiences larger fluctuations and is considered to be riskier than META based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	QNTM	META	Difference
Volatility (1M) Calculated over the trailing 1-month period	45.52%	12.90%	+32.62%
Volatility (6M) Calculated over the trailing 6-month period	110.50%	27.85%	+82.65%
Volatility (1Y) Calculated over the trailing 1-year period	154.68%	36.18%	+118.50%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	134.20%	44.18%	+90.02%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	140.35%	38.76%	+101.59%

Dividends

QNTM vs. META - Dividend Comparison

QNTM has not paid dividends to shareholders, while META's dividend yield for the trailing twelve months is around 0.38%.

Position	TTM	2025	2024
META Meta Platforms, Inc.	0.38%	0.32%	0.34%
QNTM Quantum BioPharma Ltd	0.00%	0.00%	0.00%

Financials

Frequently Asked Questions

Can I hold both QNTM and META in my portfolio?

QNTM and META have a correlation of 0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, QNTM or META?

QNTM has higher volatility (45.52%) compared to META (12.90%). In terms of maximum drawdown, QNTM dropped -99.98% vs META's -76.74%.

Which has better risk-adjusted returns?

META currently has the higher Sharpe Ratio (-0.54 vs -0.55), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.